These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34983599)
1. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population. Złowocka-Perłowska E; Tołoczko-Grabarek A; Lubiński J Hered Cancer Clin Pract; 2022 Jan; 20(1):1. PubMed ID: 34983599 [TBL] [Abstract][Full Text] [Related]
2. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674 [TBL] [Abstract][Full Text] [Related]
3. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men. Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA; Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936 [TBL] [Abstract][Full Text] [Related]
5. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies. Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer. Bıyıkoğlu M; Tanrıverdi R; Bozlu M; Şenel S; Fidancı ŞB; Tamer L; Akbay E World J Urol; 2024 Aug; 42(1):476. PubMed ID: 39115757 [TBL] [Abstract][Full Text] [Related]
7. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843 [TBL] [Abstract][Full Text] [Related]
8. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998 [TBL] [Abstract][Full Text] [Related]
9. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer. Handorf E; Crumpler N; Gross L; Giri VN J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness. Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768 [TBL] [Abstract][Full Text] [Related]
12. Homeobox B13 G84E Mutation and Prostate Cancer Risk. Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799 [TBL] [Abstract][Full Text] [Related]
13. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C; Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy. Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311 [TBL] [Abstract][Full Text] [Related]
16. G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis. Huang H; Cai B Tumour Biol; 2014 Feb; 35(2):1177-82. PubMed ID: 24026887 [TBL] [Abstract][Full Text] [Related]
17. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981 [TBL] [Abstract][Full Text] [Related]
18. Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland. Złowocka-Perłowska E; Tołoczko-Grabarek A; Narod SA; Lubiński J Hered Cancer Clin Pract; 2022 Apr; 20(1):13. PubMed ID: 35395863 [TBL] [Abstract][Full Text] [Related]
19. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk. Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772 [TBL] [Abstract][Full Text] [Related]
20. Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis. Zhang J; Xiao L; Qin Z; Xu A; Zhao K; Liang C; Miao C; Zhu J; Chen W; Hua Y; Liu Y; Zhang C; Yu Y; Su S; Wang Z Oncotarget; 2016 Oct; 7(41):67101-67110. PubMed ID: 27626483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]